Arcus Biosciences (RCUS) Accounts Payables (2017 - 2026)
Arcus Biosciences (RCUS) reported Accounts Payables of $34 million for Q2 2026, up 17.2% from $29 million a year earlier but down 12.8% from the prior quarter.
Arcus Biosciences (RCUS) Accounts Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences posted Accounts Payables of $42 million, up 133.3% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
- By year, Accounts Payables came in at $18 million in FY2024 (+5.9%), $17 million in FY2023 (-15.0%), $20 million in FY2022 (+100.0%) and $10 million in FY2021 (-36.2%).
- Five-year quarterly Accounts Payables spans a low of $10 million in Q4 2021 and a high of $42 million in Q4 2025.
- Year over year, Accounts Payables has now increased in each of the last seven quarters, with growth averaging 70.5% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q3 2025 (growth of 223.1%); the low point was Q2 2023 (a decline of 45.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $39 million (Q1 2026), $42 million (Q4 2025) and $42 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Arcus Biosciences | 3.26 Bn | -77.18 Mn | - | 34.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.00 Mn |
| Mar 31, 2026 | 39.00 Mn |
| Dec 31, 2025 | 42.00 Mn |
| Sep 30, 2025 | 42.00 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Mar 31, 2025 | 22.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 13.00 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 17.00 Mn |
| Sep 30, 2023 | 17.00 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 28.00 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 10.55 Mn |
| Jun 30, 2022 | 21.98 Mn |
| Mar 31, 2022 | 18.09 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 13.22 Mn |
Arcus Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=RCUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();